Drugs / CGB-600
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07357870 | Jul 2025 → Nov 2026 expected | vitiligo | CAGE Bio Inc. | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CGB-600 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07357870 ↗ |